what are glp-1 agonists Comparing Ozempic, Wegovy and Other Drugs GLP-1 and Anesthesia: Considerations and

Description

Eligible adults include those with an initial BMI of 30 kg/m 2 and above, or 27 to 29.9 kg/m 2 in the presence of at least one weight-associated comorbidity

GLP-1RA Mechanism of Action GLP-1 (glucagon-like peptide-1) is a hormone secreted by the intestinal tract during feeding, which enhances insulin secretion and inhibits glucagon secretion in a glucose concentration-dependent manner, and delays gastric emptying to reduce the amount of food eaten through central appetite suppression

GLP-1 Pipeline In November 2023, the FDA approved Zepbound (tirzepatide), a GLP-1 antagonist and GIP dual agonist with superior weight loss efficacy compared to its competitors

Newer GLP-1 formulations delivered weight-loss numbers rivaling those of bariatric surgery, with more than half of semaglutide trial participants losing at least 15% of their body weight over 68 weeks